In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Mevion Medical raises $150mm in late-stage round

Executive Summary

Mevion Medical Systems Inc. raised $150mm through a late-stage funding round led by YuanMing Capital. Henan Maisheng Medical Technology, HOPU Investments, and China Everbright Ltd. also participated. Mevion develops and sells proton therapy systems for cancer. The funding proceeds will support manufacturing expansion for the Hyperscan pencil beam scanning system, and will also help expand the company's business into emerging markets.
Deal Industry
  • Medical Devices
Deal Status
  • Final
Deal Type
  • Financing
    • Venture Financing

Related Companies